A pilot phase II study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA.
Jianqing Lin
No relevant relationships to disclose
Jean H. Hoffman-Censits
No relevant relationships to disclose
Danielle Duffy
No relevant relationships to disclose
Inna Chervoneva
No relevant relationships to disclose
Deborah Kilpatrick
No relevant relationships to disclose
Brooke Kennedy
No relevant relationships to disclose
Edouard John Trabulsi
No relevant relationships to disclose
Costas D. Lallas
No relevant relationships to disclose
Leonard G. Gomella
No relevant relationships to disclose
Thomas Force
No relevant relationships to disclose
William Kevin Kelly
No relevant relationships to disclose